Cook Medical renews contract with large purchasing network
Cook Medical (Bloomington, IN) recently announced the renewal of a contract that supplies its urology products to more than 2,500 U.S. hospitals.
Cook Medical (Bloomington, IN) recently announced the renewal of a contract that supplies its urology products to more than 2,500 U.S. hospitals.
The renewed contract, which began on Jan. 1, 2012, provides hospitals that are part of Premier, Inc., a large purchasing network, with Cook’s line of endourologic products, including Cook-exclusive products such as the Resonance Metallic Ureteral Stent, the NGage Nitinol Stone Extractor, and the Bigopsy Backloading Biopsy Forceps.
Cook said its contracts reduce the need for hospitals to use multiple vendors, saving time and money when managing inventory. A hospital contracting with Cook recently reported more than 50% in cost savings, the company said in a statement.
"Cook is very pleased to be continuing this partnership with Premier," said Jean-Marc Creissel, of Cook’s urology division. "This contract is a great example of the way industry can work with purchasing groups to meaningfully impact the rising costs of health care."
Go back to this issue of Urology Times eNews.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
